Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Halperin

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Cardiovascular Therapeutics|July 5, 2018
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysisZhen Ge, Michela Faggioni, Usman Baber, et al.
Journal of the American College of Cardiology|March 11, 2022
Left Ventricular Thrombus Following Acute Myocardial Infarction: JACC State-of-the-Art ReviewAnton Camaj, Valentin Fuster, Gennaro Giustino, et al.
European Heart Journal|December 5, 2013
Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AFWilliam Schuyler Jones, Anne S Hellkamp, Jonathan Halperin, et al.
Journal of the American Heart Association|July 17, 2025
Impact of Atrial Fibrillation in Patients With Severe Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge RepairCarlo Mannina, Akarsh Sharma, Yash Prakash, et al.
The American Journal of Cardiology|December 4, 2018
Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis)Serge Korjian, Yazan Daaboul, François Laliberté, et al.
ESC Heart Failure|July 3, 2020
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AFSergio J Dubner, Christine Teutsch, Menno V Huisman, et al.
Thrombosis and Haemostasis|February 5, 2016
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implicationsGary E Raskob, Alex C Spyropoulos, Julie Zrubek, et al.
The New England Journal of Medicine|December 14, 2016
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCIC Michael Gibson, Roxana Mehran, Christoph Bode, et al.
Stroke|March 7, 2008
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attackRobert J Adams, Greg Albers, Mark J Alberts, et al.
Journal of Cardiology|June 22, 2026
Neutrophil-to-Lymphocyte Ratio in Patients with Low-Flow Aortic Stenosis Undergoing Transcatheter Aortic Valve ImplantationCarlo Mannina, Esha Vaish, Eric Kim, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cardiovascular Therapeutics|July 5, 2018
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta-analysisZhen Ge, Michela Faggioni, Usman Baber, et al.
Journal of the American College of Cardiology|March 11, 2022
Left Ventricular Thrombus Following Acute Myocardial Infarction: JACC State-of-the-Art ReviewAnton Camaj, Valentin Fuster, Gennaro Giustino, et al.
European Heart Journal|December 5, 2013
Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AFWilliam Schuyler Jones, Anne S Hellkamp, Jonathan Halperin, et al.
Journal of the American Heart Association|July 17, 2025
Impact of Atrial Fibrillation in Patients With Severe Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge RepairCarlo Mannina, Akarsh Sharma, Yash Prakash, et al.
The American Journal of Cardiology|December 4, 2018
Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis)Serge Korjian, Yazan Daaboul, François Laliberté, et al.
ESC Heart Failure|July 3, 2020
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AFSergio J Dubner, Christine Teutsch, Menno V Huisman, et al.
Thrombosis and Haemostasis|February 5, 2016
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implicationsGary E Raskob, Alex C Spyropoulos, Julie Zrubek, et al.
The New England Journal of Medicine|December 14, 2016
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCIC Michael Gibson, Roxana Mehran, Christoph Bode, et al.
Stroke|March 7, 2008
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attackRobert J Adams, Greg Albers, Mark J Alberts, et al.
Journal of Cardiology|June 22, 2026
Neutrophil-to-Lymphocyte Ratio in Patients with Low-Flow Aortic Stenosis Undergoing Transcatheter Aortic Valve ImplantationCarlo Mannina, Esha Vaish, Eric Kim, et al.
Pageof 3